NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1477058816 MD
Verify on CMS → Daniel Alape Moya, MD
Pulmonary Disease Physician in Hyannis, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
376
Medicare Part D claims · 125 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
47%
generic claims · 53% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$16.64
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Daniel Alape Moya, MD filed 376 Medicare Part D claims in 2024 as a Pulmonary Disease Physician in Hyannis, Massachusetts, prescribing 47% generic.
- 376
- Part D claims, 2024
- 47%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥56th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Daniel Alape Moya, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1477058816), first enumerated 03/28/2018.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 376 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
3 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$16.64 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Massachusetts statewide board action statistics are published annually — these figures describe aggregate state activity, not Daniel Alape Moya, MD's individual license status. Verify directly with the state medical board.
Source: BORIM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1477058816 · Pulmonary Disease Physician
NPI-10 · ENUM-RECENT · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1477058816
- ENUM-RECENT 2018
- TAX-MID 10K Pulmonary Disease
- RX-LIGHT 376
- BOOK-THIN 325 in Massachusetts
- PHOTO-ENUM Vani Mulkareddy, MD · 2018
Daniel Alape Moya, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
376 ≥ 56th percentile 56% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Daniel Alape Moya, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 3 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Daniel Alape Moya, MD?
Quality data not reportedPrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
376 75% vs specialty avg
Specialty distribution in Massachusetts
How Pulmonary Disease Physician compares to other specialties among Massachusetts providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1477058816 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 03/28/2018 |
Hospital and facility affiliations
Facilities where Daniel Alape Moya, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Daniel Alape Moya, MD is affiliated with 3 Medicare-billing facilities.
Medical Affiliates OF Cape Cod Inc
Hyannis, MA
Physicians OF Cape Cod Hospital
Hyannis, MA
Physiotherapy Associates Inc
South Dennis, MA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Alape Moya, MD. Source: openpaymentsdata.cms.gov.
Total received
$17
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Daniel Alape Moya, MD. To verify Daniel Alape Moya, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Daniel Alape Moya, MD - brand share 53.0%
Pulmonary Disease Physician average
53% brand-name claims vs 47% generic, on 376 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
376
Total Claims
$161K
Total Drug Cost
125
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 601.567
- Total Day Supply
- 17,234
- Brand vs Generic
- 53% brand / 47% generic
- Brand Drug Cost
- $119K
- Generic Drug Cost
- $42K
- Antibiotic Claims
- 27
Patient Demographics
- Average Patient Age
- 74.9 years
- Avg HCC Risk Score
- 1.64
- Gender Split
- 52% female / 48% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Daniel Alape Moya, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Trelegy Ellipta
Trelegy Ellipta
46 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
35 claims
- Montelukast Sodium
Montelukast Sodium
28 claims
- Spiriva Respimat
Spiriva Respimat
22 claims
- Azelastine Hcl
Azelastine Hcl
20 claims
- Wixela Inhub
Wixela Inhub
20 claims
- Anoro Ellipta
Anoro Ellipta
19 claims
- Incruse Ellipta 18
Incruse Ellipta
18 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 46 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 35 |
| Montelukast Sodium | 28 |
| Spiriva Respimat Tiotropium Bromide | 22 |
| Azelastine Hcl | 20 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 20 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 19 |
| Incruse Ellipta Umeclidinium Bromide | 18 |
| Azithromycin | 16 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Daniel Alape Moya, MD fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Daniel Alape Moya, MD's 376 claims are below the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Alape Moya, both outside Massachusetts so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2018)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Alape Moya.
One of 325 Pulmonary Disease Physician providers enrolled in Massachusetts, 5 are shown here.
Dr. Mohammad Abu Hishmeh
M.D
Springfield, MA
Dr. Anjali Ahn
M.D.
Boston, MA
Dr. Robert Aisenberg
MD
Fall River, MA
Dr. Padmastuti Akella
MD
Worcester, MA
Ala Alkhatib
MBBS
Brighton, MA
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Daniel Alape Moya, MD's specialty? ▼
Daniel Alape Moya, MD specializes in Pulmonary Disease Physician and practices in Hyannis, Massachusetts. Credentials: MD.
How much does Daniel Alape Moya, MD prescribe under Medicare Part D? ▼
In 2024, Daniel Alape Moya, MD wrote 376 Medicare Part D claims totaling $161K in drug costs for 125 beneficiaries.
Where is Daniel Alape Moya, MD located? ▼
Daniel Alape Moya, MD is located at 46 NORTH ST STE 7, Hyannis, MA, 02601. Phone: (508) 775-2295.
What is Daniel Alape Moya, MD's NPI number? ▼
Daniel Alape Moya, MD's National Provider Identifier (NPI) is 1477058816, issued on 03/28/2018.
Does Daniel Alape Moya, MD prescribe more brand-name or generic drugs? ▼
Daniel Alape Moya, MD's prescribing is 53% brand-name and 47% generic drugs by claim count, with $119K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Daniel Alape Moya, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Daniel Alape Moya, MD's most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daniel Alape Moya, MD accept Medicare? ▼
Daniel Alape Moya, MD appears in CMS Medicare data with 376 Part D claims and 125 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daniel Alape Moya, MD's credentials? ▼
Daniel Alape Moya, MD's NPI is 1477058816 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.